Nov 5, 6:10 AM ET
Enovis reported third-quarter 2026 net sales of $559 million, up 2% on a reported basis and 5% organic, and net income of $3 million compared with a net loss of $571 million a year earlier. The company raised its full-year adjusted EBITDA and adjusted EPS guidance, narrowed its revenue guidance, and approved a new $200 million share repurchase authorization.
- Q3 net sales of $559 million, up 2% reported and 5% organic; adjusted EPS of $0.88 versus $0.75 a year earlier
- 2026 adjusted EBITDA guidance raised to $428-438 million from $425-435 million
- 2026 adjusted EPS guidance raised to $3.58-3.79 from $3.52-3.73; revenue guidance narrowed to $2.32-2.35 billion from $2.31-2.37 billion
- New $200 million share repurchase authorization replaces the existing $100 million authorization
Read the filing on SEC.gov ↗
Aug 6, 6:19 AM ET
Enovis reported second-quarter 2026 net sales of $583 million, up 3% on a reported basis and 5% organically, and a net loss of $1 million, or $0.02 per share, compared with a net loss of $36.5 million a year earlier. The company reaffirmed its full-year 2026 guidance for revenue, adjusted EBITDA, adjusted EPS and free cash flow conversion.
- Q2 net sales of $583 million, up 3% reported and 5% organic; Recon sales up 8% reported, P&R down (1)% reported
- Q2 net loss of $1 million ($0.02 per share) versus $36.5 million loss in Q2 2025; adjusted EBITDA of $104 million, or 17.9% of sales
- Adjusted EPS of $0.90 for Q2 2026; full-year guidance reaffirmed: revenue $2.31-2.37 billion, adjusted EBITDA $425-435 million, adjusted EPS $3.52-3.73
- Conference call scheduled for 8:30 a.m. Eastern on August 6, 2026
Read the filing on SEC.gov ↗
May 19, 4:54 PM ET
At its May 19, 2026 annual meeting, Enovis stockholders approved an amendment to the 2020 Omnibus Incentive Plan that authorizes 3,650,000 additional common shares and raises the annual compensation limit for outside directors from $350,000 to $750,000. Stockholders also elected ten directors, ratified Ernst & Young LLP as auditor for 2026, and approved executive compensation in a non-binding vote.
- The plan amendment authorizes 3,650,000 additional shares of common stock for issuance under the 2020 Omnibus Incentive Plan.
- The annual cap on equity and cash compensation for outside directors rises from $350,000 to $750,000, with up to 200% allowed in the year of a new election or appointment.
- The plan amendment received 50,391,554 votes for and 1,295,073 against.
- Named executive officer compensation was approved by 49,531,111 votes for and 2,175,335 against.
Read the filing on SEC.gov ↗
May 7, 6:09 AM ET
Enovis reported first-quarter 2026 net sales of $589 million, up 5% on a reported basis and 3% organic, and a net loss of $8 million, or $0.15 per share, compared with a net loss of $55.7 million a year earlier. The company reaffirmed its full-year 2026 revenue, adjusted EBITDA, adjusted EPS and free cash flow conversion guidance, which matters to shareholders because it signals no change to its outlook.
- Net sales $589 million, up 5% reported and 3% organic; Reconstructive sales up 11% reported
- Net loss $8 million ($0.15 per share) versus a $55.7 million net loss in the prior-year quarter
- Adjusted EBITDA $104 million (17.6% of sales) and adjusted EPS $0.89, versus $0.65 a year earlier
- Full-year 2026 guidance reaffirmed: revenue $2.31-2.37 billion, adjusted EBITDA $425-435 million, adjusted EPS $3.52-3.73
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.